We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

arGEN-X Enters Long-term Strategic Alliance with Shire in Therapeutic Antibodies

News   Jun 05, 2014

 
arGEN-X Enters Long-term Strategic Alliance with Shire in Therapeutic Antibodies
 
 
Advertisement
 

RELATED ARTICLES

mRNA-1273 COVID-19 Vaccine Protects Airway in Nonhuman Primate Study

News

Two doses of an experimental vaccine to prevent coronavirus disease 2019 (COVID-19) induced robust immune responses and rapidly controlled the coronavirus in the upper and lower airways of rhesus macaques exposed to SARS-CoV-2.

READ MORE

“Love Hormone” Could Be Used to Treat Alzheimer’s

News

Scientists have suggested that oxytocin, also known as the “love hormone”, could be a potential new therapeutic option for cognitive disorders such as Alzheimer's disease.

READ MORE

Wuhan COVID-19 Vaccine Trials Show Early Positive Results, Moving Forward to Phase 3 Testing

News

The adenovirus type-5-vectored COVID-19 vaccine was shown to be safe and induced significant immune responses in the majority of recipients after a single immunization.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE